MOR Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
MOR Wealth Management's AZN Position: Q3 2026 in Review
MOR Wealth Management increased its AstraZeneca (AZN) stake by 12% in Q3 2026, buying an estimated $75.2K and bringing the position to 4,160 shares worth $672K. The position accounts for 0.25% of the portfolio, ranked #59.
MOR Wealth Management first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $829K in Q1 2026. 1,444 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- MOR Wealth Management held 4,160 shares of AstraZeneca worth $672K as of Q3 2026.
- MOR Wealth Management bought 451 AstraZeneca shares in Q3 2026, an estimated $75.2K.
- AstraZeneca made up 0.25% of MOR Wealth Management's portfolio in Q3 2026, its #59 holding.
- MOR Wealth Management first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
- MOR Wealth Management's AstraZeneca position peaked at $829K in Q1 2026.
- 1,444 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on MOR Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.